John Dawry
Pharmacologist and translational drug-development leader (PhD, PharmD) with 14+ years moving assets from discovery to IND and FIH across oncology, radiopharmaceuticals, immuno-oncology, genetic engineering, and precision medicine. I lead cross-functional pharmacology/biomarker strategy, direct GLP/GCLP studies, and author CTD modules for FDA, EMA, and Health Canada. Led >25 preclinical programs; integrated PK/PD, biodistribution, histology to drive […]